Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 48 | 25 | 0 | 2 | 1 |
| Cost of Goods | N/A | N/A | N/A | 1 | 7 |
| Gross Profit | 48 | 25 | N/A | 1 | -6 |
| Operating Expenses | 3,508 | 4,860 | 4,822 | 3,856 | 3,794 |
| Operating Income | -3,460 | -4,835 | -4,822 | -3,854 | -3,793 |
| Interest Expense | 10 | 11 | 1 | 1 | 2 |
| Other Income | 195 | 25 | -222 | -148 | -114 |
| Pre-tax Income | -3,275 | -4,821 | -5,045 | -4,003 | -3,909 |
| Net Income Continuous | -3,275 | -4,821 | -5,045 | -4,003 | -3,909 |
| Net Income | $-3,275 | $-4,821 | $-5,045 | $-4,003 | $-3,909 |
| EPS Basic Total Ops | -6.80 | -10.03 | -2,108.84 | 13.61 | -13.95 |
| EPS Basic Continuous Ops | -6.82 | -10.03 | -2,099.92 | 13.62 | -14.00 |
| EPS Diluted Total Ops | -6.80 | -10.03 | -2,108.84 | 13.61 | -13.95 |
| EPS Diluted Continuous Ops | -6.82 | -10.03 | -2,099.92 | 13.62 | -14.00 |
| EBITDA(a) | $-3,406 | $-4,780 | $-4,770 | $-3,802 | $-3,726 |